RVL Pharmaceuticals plc (RVLPQ)
USD 0.0
(900.0%)
USD 0.0
(900.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 12.94 Million USD | 79.78% |
| 2021 | 7.2 Million USD | -93.31% |
| 2020 | 107.56 Million USD | -39.38% |
| 2019 | 177.43 Million USD | -10.39% |
| 2018 | 198 Million USD | -30.76% |
| 2017 | 285.94 Million USD | -7.6% |
| 2016 | 309.46 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | 25.11 Million USD | 93.96% |
| 2023 Q2 | 38.98 Million USD | 55.27% |
| 2022 Q3 | -3.09 Million USD | -118.19% |
| 2022 Q2 | 16.99 Million USD | -20.72% |
| 2022 FY | 12.94 Million USD | 79.78% |
| 2022 Q1 | 21.43 Million USD | 197.72% |
| 2022 Q4 | 12.94 Million USD | 518.69% |
| 2021 Q4 | 7.2 Million USD | -69.11% |
| 2021 FY | 7.2 Million USD | -93.31% |
| 2021 Q3 | 23.3 Million USD | 0.0% |
| 2020 FY | 107.56 Million USD | -39.38% |
| 2019 FY | 177.43 Million USD | -10.39% |
| 2018 FY | 198 Million USD | -30.76% |
| 2017 FY | 285.94 Million USD | -7.6% |
| 2016 FY | 309.46 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1310.00 USD | 988344.275% |
| Arch Therapeutics, Inc. | 5.64 Million USD | -129.199% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 69.747% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 5286.283% |
| Rebus Holdings, Inc. | 305 Thousand USD | -4144.59% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 305.345% |
| Qrons Inc. | 351.42 Thousand USD | -3583.838% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -1980.133% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 70.194% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 63535.907% |
| Skye Bioscience, Inc. | -5.72 Million USD | 326.274% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 17.871% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | -214.374% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -3121.608% |
| SQZ Biotechnologies Company | -36.23 Million USD | 135.725% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | -477.371% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | -1296.268% |
| Mesoblast Limited | 55.85 Million USD | 76.823% |
| Marizyme, Inc. | 18.56 Million USD | 30.282% |
| Genus plc | 190.6 Million USD | 93.208% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | -479.024% |
| Pharming Group N.V. | 109.8 Million USD | 88.21% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | -1404.927% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | -966.49% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | -1803.824% |
| ContraFect Corporation | -6.02 Million USD | 314.836% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -9515.342% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | -1020.45% |
| IMV Inc. | 7.67 Million USD | -68.776% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | -135.301% |
| MultiCell Technologies, Inc. | 90.04 USD | -14377954.198% |
| ONE Bio Corp. | 9.04 Million USD | -43.207% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 1863.813% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | -846.365% |
| Q BioMed Inc. | 4.06 Million USD | -218.866% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 57.629% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | -1184.687% |
| Biomind Labs Inc. | 711.4 Thousand USD | -1719.787% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 78.618% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | -547.497% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | -1.089% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -3499.01% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -9160.107% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -65063.336% |
| Curative Biotechnology, Inc. | 2.2 Million USD | -487.925% |
| GB Sciences, Inc. | 1.74 Million USD | -640.908% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 7143.985% |
| HST Global, Inc. | 96.79 Thousand USD | -13274.934% |
| CSL Limited | 10.52 Billion USD | 99.877% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -6177.853% |
| Halberd Corporation | 144.72 Thousand USD | -8845.488% |
| Enzolytics Inc. | 981.65 Thousand USD | -1218.792% |
| Agentix Corp. | 37.63 Thousand USD | -34302.487% |
| Resverlogix Corp. | 6.45 Million USD | -100.682% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 2023.371% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -2.02 Billion USD | 100.638% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 127.538% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -83.087% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -377.956% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 246.449% |
| AVAX Technologies, Inc. | -5.9 Million USD | 319.305% |
| Zenith Capital Corp. | 10.06 Thousand USD | -128536.725% |
| Genscript Biotech Corporation | -1.06 Billion USD | 101.22% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -6359.048% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | -442.574% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -7769.478% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 70773.654% |
| Kadimastem Ltd | -253.1 Thousand USD | 5214.934% |
| Helix BioMedix, Inc. | -2.57 Million USD | 603.729% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 36.151% |
| BioStem Technologies, Inc. | 4.47 Million USD | -189.489% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -6332.667% |
| LadRx Corporation | -2.03 Million USD | 735.708% |
| Cell Source, Inc. | 9.23 Million USD | -40.23% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -1938.204% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -1938.204% |
| NovAccess Global Inc. | 2.17 Million USD | -494.272% |
| Affymax, Inc. | -5.59 Million USD | 331.302% |
| Itoco Inc. | 228.3 Thousand USD | -5570.485% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -9419.888% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | -161.166% |
| Mobile Lads Corp. | 484.23 Thousand USD | -2573.512% |
| CytoDyn Inc. | 20.26 Million USD | 36.107% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 2001027.357% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 139779.813% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | -67.999% |
| SYBLEU INC | 473.71 Thousand USD | -2632.873% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | -190.463% |
| International Stem Cell Corporation | 2.59 Million USD | -399.846% |
| Bioxytran, Inc. | 1.89 Million USD | -581.758% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -20642.474% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -493.608% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | -276.995% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | -51.362% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | -1575.626% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 1135.68% |
| Neutra Corp. | 52.18 Thousand USD | -24706.944% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 620.129% |
| PureTech Health plc | -167.19 Million USD | 107.743% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 5386.067% |
| IXICO plc | -4.44 Million USD | 391.276% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 2.065% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 76.398% |
| CSL Limited | 10.52 Billion USD | 99.877% |
| Cellectis S.A. | -43.81 Million USD | 129.544% |